Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This programme funds preclinical and clinical research aimed at developing disease-modifying therapies for Parkinson's that can slow, stop, or reverse disease progression, with a strong emphasis on translational projects with potential to reach the clinic within five years.
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Júlia Vidal: [email protected] Ext.: 1736
Convocatòria (URL)
https://cureparkinsons.org.uk/research/for-researchers/apply-for-funding/quarterly-research-grant/
Informació addicional
The call has three application deadlines:
  • 13 April 2026
  • 22 June 2026
  • 12 October 2026
  • Requisits
    Applications are accepted from both academic and commercial entities.
    Dotació
    £250,000
    Durada
    5 years
    Documentació
    The call follows a two-stage submission process. The following documentation must be submitted by email to [email protected]:
  • Stage 1 application form
  • Drug and compound CV (if applicable)
  • Commercial entity form (if applicable)
    Additional documents that may be included at Stage 1 but are not mandatory:
  • Principal Investigator / Co-Investigator CVs
  • Budget breakdown
  • Any supplementary documents supporting the application (preliminary data, clinical trial protocol, publications)
  • Arxius

    Arxiu
    Cure-Parkinsons-Stage-1-Application-Form-V1.2.docx
    Cure-Parkinsons-Budget-Guidance-for-Applicants-V1.pdf
    Cure-Parkinsons-Guidance-for-Applicants.pdf
    Cure-Parkinsons-Drug-and-Compound-CV-V1.1.docx
    Cure-Parkinsons-Commercial-Entity-Form.docx